Micafungin Salvage Mono-therapy in Invasive Aspergillosis

Summary

To evaluate the efficacy and safety of micafungin in patients with proven invasive aspergillosis and who are refractory or intolerant to previous systemic antifungal therapy. To compare the efficacy and safety of the micafungin therapy with the active control arm

Timeline

Start

2006-06

Primary completion

2008-09

Completion

2008-09

Outcome

Outcome not reported

Stopped (Enrollment): “Study was stopped due to difficulties in recruitment and changes in standard care for invasive aspergillosis”

Drugs

Indications